In our study, bioinformatics analysis revealed that APOC1 is highly expressed in DLBCL, a finding further confirmed in clinical samples, where APOC1 levels were significantly higher in DLBCL samples compared to RHL samples. This evidence concerns the gene APOC1 and diffuse large B-cell lymphoma.